The diagnosis of mild cognitive impairment (MCI) often represents prodromal Alzheimer's disease or other dementia. However, diagnosis, prediction of outcome, and treatment of patients with mild cognitive impairment presents many challenges. Faculty will address the diagnosis, pathophysiology, role of biomarkers, and treatment of mild cognitive impairment.

Completion Message:

Participants should be able to understand the basic biology of MCI and be familiar with the recommended diagnostic strategy, appropriate use of biomarkers, and management of patients with MCI.